MHRA — authorised 15 September 2023
- Status: approved
MHRA authorised Abrysvo on 15 September 2023
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MHRA authorised it on 15 September 2023.
Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.